- Did the top line miss?
- Did the bottom line miss?
- Did the stock do nothing or go up anyway?
A series of questions denigrated an amazing company.
IBM stock is declining after the company's board approved a new stock buyback plan and quarterly dividend.
Tech giants, Big Pharma and insurers are all angling to profit from the $3 trillion-plus U.S. healthcare market.